Explore the reality of the 20-year drug patent term. Learn how regulatory delays, extensions, and exclusivity periods affect generic entry and medication prices.
Authorized generics are identical copies of brand-name drugs made by the original manufacturer, launched to compete with generics after patent expiration. They lower prices, maintain consistency, and confuse patients-here's how they work.
Partial AUC is a key tool in bioequivalence testing for complex generic drugs, helping regulators ensure safe and effective absorption patterns beyond traditional metrics like Cmax and total AUC.
The Hatch-Waxman Amendments of 1984 created the modern generic drug industry by balancing innovation incentives with faster market access. Today, 90% of U.S. prescriptions are generic, saving billions annually.
